Teva’s largest in a decade — “makes sense” given the synergies between Emalex and the pharmaceutical giant’s neurology ...

Teva Pharmaceutical Industries agreed to acquire Emalex Biosciences in a deal valued at $900 million. The acquisition centers ...

Q4 2025 Earnings Call April 28, 2026 8:00 AM EDTCompany ParticipantsJan Keppeler - Head of Investor Relations, Sustainability ...

The unfaithful spouse often feels guilty about their affair, but also guilty and conflicted about ending it. Ceasing contact ...

A genetic alteration that is already routinely analyzed in patients with acute myeloid leukemia can be used to identify patients who respond to a new targeted therapy, according to a study published ...

Each year, 20 million people are diagnosed with cancer. Various organs can be affected, and cancer types sometimes differ ...

Older adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms ...

A TG2 inhibitor reduced gluten-triggered immune and metabolic changes throughout the body. The approach restored blood ...